Clinical Trial Update: The LEADLESS Observational Study

View source ↗

Summary

Abbott-led LEADLESS observational study evaluating indications for leadless VVI(R) pacemakers; results were posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Block
• Bradycardia

Drugs mentioned

• VVI(R) Pacemaker (leadless)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Indications for VVI(R) Pacemaker | Status: COMPLETED | Results posted: 2025-06-06